|
Volumn 51, Issue 13, 2015, Pages 2585-2588
|
Multi-synergetic ZnO platform for high performance cancer therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DAUNORUBICIN;
DRUG CARRIER;
NANOROD;
ZINC OXIDE;
ANTINEOPLASTIC AGENT;
A549 CELL LINE;
ADSORPTION;
ARTICLE;
CANCER CELL DESTRUCTION;
CANCER THERAPY;
CELL DEATH;
CELL VIABILITY;
CONFOCAL LASER MICROSCOPY;
CYTOTOXICITY;
DECOMPOSITION;
DRUG EFFICACY;
DRUG RELEASE;
ELECTRON DIFFRACTION;
ENCAPSULATION;
ENDOCYTOSIS;
HYDRODYNAMICS;
ILLUMINATION;
INTERNALIZATION;
LOW TEMPERATURE;
LYSOSOME;
MTT ASSAY;
PARTICLE SIZE;
PH;
PHOTODYNAMICS;
PROTON TRANSPORT;
SOLUBILITY;
STATIC ELECTRICITY;
SYNTHESIS;
TRANSMISSION ELECTRON MICROSCOPY;
ULTRAVIOLET IRRADIATION;
CELL PROLIFERATION;
CHEMISTRY;
DRUG EFFECTS;
DRUG SCREENING;
HUMAN;
LUNG NEOPLASMS;
PATHOLOGY;
POROSITY;
STRUCTURE ACTIVITY RELATION;
SURFACE PROPERTY;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
CELL DEATH;
CELL LINE, TUMOR;
CELL PROLIFERATION;
DAUNORUBICIN;
DRUG CARRIERS;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
LUNG NEOPLASMS;
PARTICLE SIZE;
POROSITY;
STRUCTURE-ACTIVITY RELATIONSHIP;
SURFACE PROPERTIES;
ZINC OXIDE;
|
EID: 84922670656
PISSN: 13597345
EISSN: 1364548X
Source Type: Journal
DOI: 10.1039/c4cc10037a Document Type: Article |
Times cited : (18)
|
References (34)
|